Biotricity, Inc. (BTCY)
USD 0.35
(3.83%)
USD 0.35
(3.83%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 12.06 Million USD | 25.15% |
| 2023 | 9.63 Million USD | 26.0% |
| 2022 | 7.65 Million USD | 126.02% |
| 2021 | 3.38 Million USD | 138.75% |
| 2020 | 1.41 Million USD | 256.03% |
| 2019 | 398.2 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 12.06 Million USD | 25.15% |
| 2024 Q1 | 3.02 Million USD | 10.15% |
| 2024 Q3 | 2.97 Million USD | 2.82% |
| 2024 Q4 | 3.17 Million USD | 6.91% |
| 2024 Q2 | 2.89 Million USD | -4.29% |
| 2023 Q3 | 2.45 Million USD | 3.27% |
| 2023 Q2 | 2.38 Million USD | 15.82% |
| 2023 FY | 9.63 Million USD | 26.0% |
| 2023 Q1 | 2.05 Million USD | -4.31% |
| 2023 Q4 | 2.74 Million USD | 11.52% |
| 2022 Q4 | 2.14 Million USD | 11.33% |
| 2022 Q3 | 1.93 Million USD | 6.79% |
| 2022 Q2 | 1.8 Million USD | 2.45% |
| 2022 Q1 | 1.76 Million USD | 48.62% |
| 2022 FY | 7.65 Million USD | 126.02% |
| 2021 Q1 | 451.89 Thousand USD | 24.52% |
| 2021 FY | 3.38 Million USD | 138.75% |
| 2021 Q2 | 744.58 Thousand USD | 64.77% |
| 2021 Q3 | 1 Million USD | 34.47% |
| 2021 Q4 | 1.18 Million USD | 18.55% |
| 2020 Q2 | 345.9 Thousand USD | 5.78% |
| 2020 Q3 | 381.89 Thousand USD | 10.41% |
| 2020 FY | 1.41 Million USD | 256.03% |
| 2020 Q1 | 327 Thousand USD | 83.56% |
| 2020 Q4 | 362.92 Thousand USD | -4.97% |
| 2019 Q1 | 17.66 Thousand USD | 0.0% |
| 2019 FY | 398.2 Thousand USD | 0.0% |
| 2019 Q3 | 117.64 Thousand USD | 38.79% |
| 2019 Q2 | 84.76 Thousand USD | 379.95% |
| 2019 Q4 | 178.14 Thousand USD | 51.43% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | -68.388% |
| Cerus Corporation | 156.36 Million USD | 92.285% |
| OrthoPediatrics Corp. | 148.73 Million USD | 91.889% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -1145.305% |
| Talis Biomedical Corporation | 412 Thousand USD | -2827.996% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 12.591% |
| Inogen, Inc. | 315.66 Million USD | 96.178% |
| Spectral AI, Inc. | 18.05 Million USD | 33.189% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -21.79% |
| CVRx, Inc. | 39.29 Million USD | 69.301% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -1773.19% |
| Orthofix Medical Inc. | 746.64 Million USD | 98.384% |
| Venus Concept Inc. | 76.35 Million USD | 84.201% |
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -0.036% |
| Bioventus Inc. | 512.34 Million USD | 97.645% |
| BrainsWay Ltd. | 31.78 Million USD | 62.047% |
| Envoy Medical, Inc. | 316 Thousand USD | -3717.514% |
| electroCore, Inc. | 16.03 Million USD | 24.745% |
| IceCure Medical Ltd | 3.22 Million USD | -273.594% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -396.843% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -3205.035% |
| MaxCyte, Inc. | 41.28 Million USD | 70.782% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -517.86% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -10792.608% |
| PAVmed Inc | 2.45 Million USD | -391.98% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 46.43% |
| RxSight, Inc. | 89.07 Million USD | 86.457% |
| Sight Sciences, Inc. | 81.05 Million USD | 85.117% |
| SI-BONE, Inc. | 138.88 Million USD | 91.314% |
| TELA Bio, Inc. | 58.45 Million USD | 79.362% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 34.831% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 93.553% |
| LivaNova PLC | 1.15 Billion USD | 98.954% |
| 908 Devices Inc. | 50.22 Million USD | 75.983% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 97.499% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -15557.735% |
| NeuroPace, Inc. | 65.42 Million USD | 81.56% |
| LENSAR, Inc. | 42.16 Million USD | 71.389% |
| Apyx Medical Corporation | 52.34 Million USD | 76.956% |
| Cutera, Inc. | 212.36 Million USD | 94.32% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 63.837% |
| BioSig Technologies, Inc. | 18 Thousand USD | -66918.583% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 92.762% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 49.642% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.217% |
| Axonics, Inc. | 366.37 Million USD | 96.707% |
| Outset Medical, Inc. | 130.37 Million USD | 90.747% |
| IRIDEX Corporation | 51.86 Million USD | 76.743% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 91.142% |
| IRadimed Corporation | 65.56 Million USD | 81.6% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -925.795% |
| INVO Bioscience, Inc. | 3.02 Million USD | -299.372% |
| Telesis Bio, Inc. | 27.5 Million USD | 56.148% |
| Viemed Healthcare, Inc. | 183 Million USD | 93.408% |
| Varex Imaging Corporation | 811 Million USD | 98.513% |
| Quipt Home Medical Corp. | 221.74 Million USD | 94.56% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 82.434% |
| Dynatronics Corporation | 32.53 Million USD | 62.921% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -39.011% |
| Semler Scientific, Inc. | 68.18 Million USD | 82.308% |
| InMode Ltd. | 492.04 Million USD | 97.548% |
| Bruker Corporation | 2.96 Billion USD | 99.593% |
| Cytosorbents Corporation | 36.34 Million USD | 66.813% |
| DexCom, Inc. | 3.62 Billion USD | 99.667% |
| Align Technology, Inc. | 3.86 Billion USD | 99.688% |
| Viveve Medical, Inc. | 6.42 Million USD | -87.727% |
| ZimVie Inc. | 457.43 Million USD | 97.363% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 93.75% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -10792.608% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 98.387% |
| Profound Medical Corp. | 7.33 Million USD | -64.552% |
| Insulet Corporation | 1.69 Billion USD | 99.289% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 90.432% |
| iCAD, Inc. | 17.31 Million USD | 30.342% |
| Nuwellis, Inc. | 8.86 Million USD | -36.094% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 97.551% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -94.413% |
| PAVmed Inc. | 2.45 Million USD | -391.98% |
| BIOLASE, Inc. | 49.16 Million USD | 75.463% |
| Beyond Air, Inc. | 1.15 Million USD | -940.841% |
| FONAR Corporation | 102.88 Million USD | 88.275% |
| AxoGen, Inc. | 159.01 Million USD | 92.414% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 95.604% |
| Inari Medical, Inc. | 493.63 Million USD | 97.556% |
| UFP Technologies, Inc. | 400.07 Million USD | 96.985% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -64756.694% |
| Tenon Medical, Inc. | 2.92 Million USD | -311.999% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -77.089% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.623% |
| Sintx Technologies, Inc. | 2.62 Million USD | -359.206% |
| NanoVibronix, Inc. | 2.28 Million USD | -428.399% |
| Quanterix Corporation | 122.36 Million USD | 90.142% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 50.57% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 93.984% |
| TransMedics Group, Inc. | 241.62 Million USD | 95.007% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 12.925% |
| NeuroMetrix, Inc. | 5.9 Million USD | -104.414% |
| Hyperfine, Inc. | 11.03 Million USD | -9.349% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 92.696% |
| Biomerica, Inc. | 5.41 Million USD | -122.776% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 76.141% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 93.19% |